logo
HCLTech starts the year strong, but margins raise worry

HCLTech starts the year strong, but margins raise worry

Mint6 hours ago
HCL Technologies Ltd reported better-than-expected revenue in the June quarter and now sees full-year growth at 3-5% against 2-5% earlier, but the management lowering its full-year profitability by 100 basis points was a sore spot.
On Monday, the country's third-largest information technology (IT) services company reported $3.55 billion revenue for the June quarter, up 1.34% sequentially. The performance exceeded expectations of 37 analysts polled by Bloomberg, who expected HCLTech to report $3.53 billion in revenue. This was its best first quarter in six years.
HCLTech performed better than larger peer Tata Consultancy Services (TCS) in a lumpy first quarter because of its Europe business, and expects a stable FY26 despite lingering macroeconomic uncertainty. TCS ended the first quarter with $7.42 billion in revenue, down 0.59% sequentially.
The Noida-headquartered company's management sounded confident.
'We observed that the environment remains stable from an overall perspective, with some variations across specific verticals. It also did not deteriorate as feared at the start of the quarter,' said C Vijayakumar, chief executive of HCLTech, as part of his prepared remarks during the company's post-earnings press conference on Monday.
Vijayakumar's commentary is in contrast to TCS chief executive K. Krithivasan, who called out delays in decision-making and project starts with respect to discretionary investments.
The HCLTech management narrowed its revenue guidance for the full year. The company now expects revenue growth between 3% and 5% in constant currency terms, higher than its 2% guidance on the lower end it had called out in April. Constant currency does not take currency fluctuations into account.
While TCS's Krithivasan said that non-essential tech spending, which is crucial in boosting revenue of homegrown IT outsourcers, must be back once uncertainty lifts, Vijayakumar was optimistic of growth along expected lines.
'We are optimistic about meeting a revised guidance supported by our superior revenue growth and positive booking expectations for the upcoming quarters,' said Vijayakumar.
For now, most of the company's incremental business of $47 million came from businesses based in Europe, which contributed 87% of it. HCL gets almost a third of its business from Europe.
In terms of verticals, much of the incremental revenue came from banks and financial institutions, which makes up a little more than a fifth of the company's business and is its largest cash cow. HCLTech got $766 million from financial institutions last quarter.
However, there were bigger causes of concern. The Noida-based IT outsourcer reported $450 million in net profit, down 9.3% sequentially. This was the company's second successive quarter of net profit decline.
HCLTech's operating margins also raised concerns. Its profitability declined 160 basis points to 16.9% during the quarter. One basis point is a hundredth of a percentage point. The company even reduced its operating margin band to 17-18% for the full year as against its 18-19% target in April.
Chief financial officer Shiv Walia called it one-time impact, attributing the drop to a bunch of factors, adding 'specialized hiring as well as skill and location mismatch and a one-off impact of customer bankruptcy' caused the margins to drop, among other smaller factors.
While the software products business is historically its primary margin booster, operating margins for this vertical declined 190 basis points sequentially to end at 22.4% for the June quarter.
Notably, HCLTech is one of the few large IT outsourcers that has a sizeable reliance on selling and licensing revenue of software products. Its revenue from its software business fell 4.6% on a quarterly basis to $330 million; still, the bigger impact of this arm is on the company's operating margins.
Unlike TCS, HCLTech reduced headcount in the quarter. The company cut staff by 269 in the April-June 2025 period to end with 223,151, whereas TCS added 5,090 people in the first three months of the fiscal to end with 613,069 employees.
Two of the country's three largest IT outsourcers adding headcount implies better signs ahead. More headcount in an IT services company means more demand for IT services and vice-versa.
This increase in headcount comes on the backdrop of a tariff war started by US president Donald Trump coupled with geopolitical uncertainties. Both have put IT spends of large companies, many of whom count HCLTech as their IT vendor, in limbo.
The company also highlighted a restructuring plan that was put in place.
'The restructuring consists of two components. One is a lot of facilities that we are not utilizing, mostly in locations outside India, is something which we believe we should optimize, because we have not been using some of these facilities, especially some of it related to our acquisitions,' said Vijayakumar.
He also mentioned that the headcount would be cut because of the programme, in order to get to the company's 18-19% operating margin aspiration.
'The second is also that there will be some talent ramp-down that has happened, especially in some of the geographies outside India,' said Vijayakumar, adding that the upper end of its guidance factored a cost component to its restructuring programme.
Like TCS, HCLTech did not call out orders or revenue from Gen AI, but announced a dividend of ₹ 12 per share.
The company's shares fell 1.41% to close at ₹ 1,614 on Monday. The 30-share benchmark BSE Sensex index closed 0.3% lower at 82,253.46 points. The earnings were announced after market hours.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Smartworks Coworking Spaces IPO gets subscribed 13.45 times
Smartworks Coworking Spaces IPO gets subscribed 13.45 times

Time of India

time3 hours ago

  • Time of India

Smartworks Coworking Spaces IPO gets subscribed 13.45 times

NEW DELHI: The Rs 583-crore initial public offer of Smartworks Coworking Spaces Ltd garnered 13.45 times subscription on the closing day of bidding on Monday. The three-day IPO received bids for 13,99,08,852 shares against 1,04,01,828 shares on offer, as per NSE data. The portion for Qualified Institutional Buyers (QIBs) attracted 24.41 times subscription. Non-Institutional Investors part got subscribed 22.78 times and Retail Individual Investors (RIIs) part received 3.53 times subscription. Smartworks Coworking Spaces has raised Rs 173.64 crore from anchor investors. The IPO of Smartworks Coworking Spaces hit the capital market on Thursday last week to raise nearly Rs 600 crore as the company intends to expand its business and reduce debt. The company has fixed a price band of Rs 387-407 per share for its IPO. The size of the fresh issue has been reduced to Rs 445 crore from the earlier planned Rs 550 crore, while the offer for sale (OFS) by promoters has been cut to 33.79 lakh shares from 67.59 lakh shares. Of the total proceeds from the fresh issue of shares, the company will use Rs 226 crore for capital expenditure related to the fit-outs in new centres and security deposits for these new centres. It will utilise Rs 114 crore for payment of loans, and the remaining funds will be used for general corporate purposes. The OFS proceeds will go to promoters. Gurugram-based Smartworks, one of the leading managed flexible office space providers, has 48 operational co-working centres with over 1.9 lakh seating capacities. JM Financial Ltd, BOB Capital Markets Ltd and IIFL Capital Services Ltd are the book-running lead managers to the IPO.

Sun Pharma settles litigation with Incyte Corp over hair loss drug Leqselvi
Sun Pharma settles litigation with Incyte Corp over hair loss drug Leqselvi

Economic Times

time3 hours ago

  • Economic Times

Sun Pharma settles litigation with Incyte Corp over hair loss drug Leqselvi

Synopsis Sun Pharmaceutical Industries has reached a settlement agreement with Incyte Corporation concerning Leqselvi, a drug for severe hair loss, leading to the dismissal of pending litigation in the US. Incyte has granted Sun a non-exclusive license for oral deuruxolitinib for specific non-oncology indications, including alopecia areata, in the US. Reuters Sun pharma logo( File photo) Sun Pharmaceutical Industries on Monday said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for severe hair the terms of agreement, the parties will seek dismissal of the pending Leqselvi litigation in the US District Court for the District of New Jersey, and Sun and Incyte will mutually release each other of all claims that were raised or could have been raised in that litigation, the Mumbai-based drug major said in a statement. As a part of the agreement, Incyte has granted to Sun a limited, non-exclusive license to US Patent Nos. 9,662,335 and certain other related patents with respect to oral deuruxolitinib for certain agreed-upon non-hematology-oncology indications, including alopecia areata, in the US, it added. Sun will pay Incyte an upfront amount, plus ongoing royalty payments until the expiry of the patents, in exchange for the settlement and license, it stated. Other specific terms of the settlement and license agreement are confidential, it added. In a separate statement, the drug firm announced the launch of Leqselvi (8 mg) tablets in the US medication (deuruxolitinib) is indicated for the treatment of adults with severe alopecia areata."The launch of Leqselvi in the US brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them," Richard Ascroft, CEO of Sun Pharma North America, said."As a company committed to launching new therapeutic options which address the unmet needs of patients, adding Leqselvi to our dermatology portfolio represents a key milestone for the business and an important advancement for the alopecia areata community," he added. Shares of Sun Pharma ended 0.54 per cent higher at Rs 1,681.45 apiece on the BSE.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store